LTFS
TGTX icon

Ladenburg Thalmann Financial Services’s TG Therapeutics TGTX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$104K Buy
9,327
+3,000
+47% +$22.8K ﹤0.01% 2984
2019
Q3 		$36K Sell
6,327
-1,700
-21% -$11.9K ﹤0.01% 3664
2019
Q2 		$69K Buy
8,027
+1,100
+16% +$8.32K ﹤0.01% 3239
2019
Q1 		$56K Buy
6,927
+2,200
+47% +$11.9K ﹤0.01% 3335
2018
Q4 		$19K Sell
4,727
-1,000
-17% -$4.97K ﹤0.01% 3906
2018
Q3 		$32K Hold
5,727
– – ﹤0.01% 3615
2018
Q2 		$81K Hold
5,727
– – ﹤0.01% 2893
2018
Q1 		$81K Hold
5,727
– – ﹤0.01% 2893
2017
Q4 		$47K Hold
5,727
– – ﹤0.01% 3261
2017
Q3 		$68K Buy
5,727
+1,000
+21% +$11.4K ﹤0.01% 2871
2017
Q2 		$48K Buy
4,727
+2,600
+122% +$29.1K ﹤0.01% 3058
2017
Q1 		$25K Sell
2,127
-412
-16% -$2.96K ﹤0.01% 3414
2016
Q4 		$16K Hold
2,539
– – ﹤0.01% 3619
2016
Q3 		$20K Hold
2,539
– – ﹤0.01% 3414
2016
Q2 		$16K Buy
2,539
+1,412
+125% +$11.5K ﹤0.01% 3492
2016
Q1 		$10K Hold
1,127
– – ﹤0.01% 3714
2015
Q4 		$13K Hold
1,127
– – ﹤0.01% 3528
2015
Q3 		$11K Hold
1,127
– – ﹤0.01% 3480
2015
Q2 		$19K Sell
1,127
-2,150
-66% -$34K ﹤0.01% 3278
2015
Q1 		$51K Buy
3,277
+1,150
+54% +$17.4K ﹤0.01% 2543
2014
Q4 		$34K Buy
2,127
+400
+23% +$5.21K ﹤0.01% 2613
2014
Q3 		$18K Sell
1,727
-1,070
-38% -$9.92K ﹤0.01% 2754
2014
Q2 		$26K Hold
2,797
– – ﹤0.01% 2468
2014
Q1 		$19K Buy
2,797
+1,247
+80% +$7.38K ﹤0.01% 2617
2013
Q4 		$6K Buy
+1,550
New +$6.26K ﹤0.01% 3184

Other funds holding TGTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ladenburg Thalmann Financial Services's TGTX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its TG Therapeutics (TGTX) stake by 47% in Q4 2019, buying an estimated $22.8K and bringing the position to 9,327 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #2984.

Ladenburg Thalmann Financial Services first reported a position in TGTX in Q4 2013 and has held it in 25 quarters since. 135 funds tracked by Wall St. Rank hold TGTX as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 9,327 shares of TG Therapeutics worth $104K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 3,000 TG Therapeutics shares in Q4 2019, an estimated $22.8K.
  • TG Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2984 holding.
  • Ladenburg Thalmann Financial Services first reported a position in TG Therapeutics in Q4 2013 and has held it in 25 quarters since.
  • 135 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.